Table II.
Quantitation of HRP Label in Pericentriolar ARF6-positive Vesicles Relative to Other Small Vesicles (<200-nm Diameter)
| Cells transfected with | Small vesicles (<200 nm) | ARF6-positive vesicles | ||||||
|---|---|---|---|---|---|---|---|---|
| Minutes post uptake | ||||||||
| 5 | 60 | 5 | 60 | |||||
| ARF6 | 34 | 173 | 0 | 12 | ||||
| ARF6(Q67L) | 21 | 112 | 0 | 0 | ||||
| ARF6(T27N) | 59 | 189 | 0 | 28 | ||||
| Vector | 89 | 342 | − | − | ||||
CHO cells on monolayers expressing ARF6 wild-type or mutant proteins were incubated with HRP as described in Materials and Methods. Monolalyers were quickly rinsed, fixed, and processed for cryoimmunogold labeling and doubled-labeled with antibodies directed against ARF6 followed by protein A–10-nm gold and against HRP followed by protein A–5-nm gold as described in Materials and Methods. The data represents an average of 5-nm gold particle count obtained from 25 cells for each condition.